An Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-care Ultrasound (POCUS), and Transthoracic Echocardiophy (TTE) to Estimate the Under-diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Across a Diverse Range of US Health Systems.
ACTIVE_NOT_RECRUITING
Status
Conditions
- Transthyretin (TTR) Amyloid Cardiomyopathy
Interventions
- DIAGNOSTIC_TEST: AI Toolkit for ATTR-CM Diagnosis
Sponsor
Yale University
Collaborators